Original Article

You have full text access to this OnlineOpen article

Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma†

  1. Mouhammed J. Kyasa1,
  2. Rudolph S. Parrish2,
  3. Steven A. Schichman3,
  4. Clive S. Zent1,3,*

Article first published online: 25 AUG 2003

DOI: 10.1002/ajh.10369

Issue

American Journal of Hematology

American Journal of Hematology

Volume 74, Issue 1, pages 1–8, September 2003

Additional Information

How to Cite

Kyasa, M. J., Parrish, R. S., Schichman, S. A. and Zent, C. S. (2003), Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma. Am. J. Hematol., 74: 1–8. doi: 10.1002/ajh.10369

Author Information

  1. 1

    Division of Hematology/Oncology, Department of Medicine, Central Arkansas Veterans Healthcare System (CAVHS) and University of Arkansas for Medical Sciences (UAMS), Little Rock, Arkansas

  2. 2

    Division of Biometry and Department of Biostatistics, UAMS, Little Rock, Arkansas

  3. 3

    Pathology and Laboratory Medicine Service, CAVHS, and Department of Pathology, UAMS, Little Rock, Arkansas

*Division of Hematology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905

  • †

    This article is a U.S. Government work and, as such, is in the public domain in the United States of America.

Publication History

  1. Issue published online: 25 AUG 2003
  2. Article first published online: 25 AUG 2003
  3. Manuscript Accepted: 15 APR 2003
  4. Manuscript Received: 17 JUL 2002

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (93K)

REFERENCES

  • 1
    Zent CS, Kyasa MJ, Evans R, Schichman SA. Chronic lymphocytic leukemia incidence is substantially higher than estimated from tumor registry data. Cancer 2001;92:1325–1330.
    Direct Link:
  • 2
    Engelfriet C, Overbeeke M, von dem Borne A. Autoimmune hemolytic anemia. Semin Hematol 1992;29:3–12.
  • 3
    Diehl L, Ketchum L. Autoimmune disease and chronic lymphocytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia. Semin Oncol 1998;25:80–97.
  • 4
    Hamblin T. Autoimmune disease and its management in chronic lymphocytic leukemia. In: ChesonB, editor. Chronic lymphocytic leukemias. 2nd edition. New York: Marcel Dekker; 2001. p 435–458.
  • 5
    Mauro F, Foa R, Cerretti R, et al. Autoimmune hemolytic anemia in chronic lymphocytic leukemia: clinical, therapeutic, and prognostic features. Blood 2000;95:2786–2792.
  • 6
    Gehrs B, Friedberg R. Autoimmune hemolytic anemia. Am J Hematol 2002;69:258–271.
    Direct Link:
  • 7
    Majumdar G, Brown S, Slater G, Singh A. Clinical spectrum of autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia. Leuk Lymphoma 1993;9:149–151.
  • 8
    Yoo D, Pierce L, Lessin L. Acquired pure red cell aplasia associated with chronic lymphocytic leukemia. Cancer 1983;51:844–850.
    Direct Link:
  • 9
    Dighiero G, Binet J-L. When and how to treat chronic lymphocytic leukemia. N Engl J Med 2000;343:1799–1801.
  • 10
    Molica S. Prognostic factors in chronic lymphocytic leukemia. In: ChesonB, editor. Chronic lymphocytic leukemias. 2nd edition. New York: Marcel Dekker; 2001. p 231–260.
  • 11
    Rai K, Sawitsky A, Cronkite E, Chanana A, Levy R, Pasternack B. Clinical staging of chronic lymphocytic leukemia. Blood 1975;46:219–234.
  • 12
    Cheson BD, Bennett JM, Grever M, et al. National Cancer Institute-Sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996;87:4990–4997.
  • 13
    Binet J, Auquier A, Dighiero G, et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 1981;48:198–205.
    Direct Link:
  • 14
    Myint H, Copplestone J, Orchard J, et al. Fludarabine-related autoimmune hemolytic anaemia in patients with chronic lymphocytic leukaemia. Br J Haematol 1995;91:341–344.
    Direct Link:
  • 15
    Cheson B, Bennett J, Rai K, et al. Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group. Am J Hematol 1988;29:152–163.
    Direct Link:
  • 16
    National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project. Cancer 1982;49:2112–2135.
    Direct Link:
  • 17
    Harris N, Jaffe E, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361–1392.
  • 18
    Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457–481.
  • 19
    Hamblin T, Oscier D, Young B. Autoimmunity in chronic lymphocytic leukaemia. J Clin Pathol 1986;39:713–716.
  • 20
    Bergsagel D. The chronic leukemias: a review of disease manifestations and the aims of therapy. Can Med Assoc J 1967;96:1615–1620.
  • 21
    Lischner M, Prokocimer M, Zolberg A, Shaklai M. Autoimmunity in chronic lymphocytic leukemia. Postgrad Med J 1988;64:590–592.
  • 22
    Pritsch O, Maloum K, Dighiero G. Basic biology of autoimmune phenomena in chronic lymphocytic leukemia. Semin Oncol 1998;25:34–41.
  • 23
    Bartik MM, Welker D, Kay NE. Impairments in immune cell function in B cell chronic lymphocytic leukemia. Semin Oncol 1998;25:27–33.
  • 24
    Scrivener S, Kaminski E, Demaine A, Prentice A. Analysis of the expression of critical activation/interaction markers on peripheral blood T cells in B-cell chronic lymphocytic leukaemia: evidence of immune dysregulation. Br J Haematol 2001;112:959–964.
    Direct Link:
  • 25
    Chemnitz J, Draube A, Diehl V, Wolf J. Successful treatment of steroid and cyclophosphamide-resistant hemolysis in chronic lymphocytic leukemia with rituximab. Am J Hematol 2002;69:232–233.
    Direct Link:
  • 26
    Iannitto E, Ammatuna E, Marino C, Cirrincione S, Greco G, Mariani G. Sustained response of refractory chronic lymphocytic leukemia in progression complicated by acute hemolytic anemia to anti-CD20 monoclonal antibody. Blood 2002;99:1096–1097.
  • 27
    Ghazal H. Successful treatment of pure red cell aplasia with rituximab in patients with chronic lymphocytic leukemia. Blood 2002;99(3):1092–1094.
  • 28
    Mandelli F, De Rossi G, Mancini P, et al. Prognosis in chronic lymphocytic leukemia: a retrospective multicentric study from the GIMEMA group. J Clin Oncol 1987;5:398–406.
Get PDF (93K)